Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cell Therapy Catapult to work with GSK on Cell Therapies

Published: Wednesday, May 22, 2013
Last Updated: Wednesday, May 22, 2013
Bookmark and Share
First partnership with large pharma company for Cell Therapy Catapult.

The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, will be working with GlaxoSmithKline plc (GSK) to explore potential collaborations in a range of areas relevant to the development of cell therapies, from research projects to technical and regulatory strategy.

The Cell Therapy Catapult is a centre of excellence for cell therapy and regenerative medicine established in 2012 to stimulate innovation in this area. Its staff are experts in cell therapy, from clinical and regulatory strategy to process development, scale-up and business development, and are focused on sharing their insight across the cell therapy sector in the UK. GSK is currently developing a bone marrow-derived stem cell gene therapy through late phase development and has a small number of collaborations in this field.

Keith Thompson, CEO of the Cell Therapy Catapult, said: ‘As it is a leading player in the global pharmaceutical industry and a strong supporter of UK science and innovation, it is very pleasing that our first ‘big pharma’ partnership is with GlaxoSmithKline. We look forward to sharing expertise and working together, an interaction which we expect to add significant value to the UK cell therapy industry.’

Jan Thirkettle, Head of Advanced Therapy Delivery at GSK, said: ‘We are pleased to be working with the Cell Therapy Catapult which is well placed to facilitate development of best practice and build a skills base which we believe will be critical to the progression of this new and technically challenging field.’


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cell Therapy Catapult is now the Cell and Gene Therapy Catapult
Cell Therapy Catapult has announced change of its name to the Cell and Gene Therapy Catapult.
Tuesday, February 09, 2016
Cell Therapy Catapult Signs Agreement with Kanagawa Prefecture, Japan
The Cell Therapy Catapult has announced the signing of a memorandum of understanding with the Kanagawa Prefecture of Japan.
Monday, November 30, 2015
UK Allots £55m for Large-Scale Cell Therapy Manufacturing Centre
The centre, which is expected to open in 2016/17, will be managed by the Cell Therapy Catapult and will provide large-scale manufacturing facilities.
Thursday, March 20, 2014
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!